The latest health and social care news and a look at research and development into the treatment of common and rare diseases alike. We also look at the vital changes being made to help deliver effective healthcare through the digital transformation within the NHS.
New WRES data shows 12.7% of very senior NHS managers are from Black & minority ethnic backgrounds, up from 11.2% in 2023, a significant rise since 2018.
A study finds that broad-spectrum antibiotics are prescribed due to a lack of resources for GPs - with "time-consuming microbiological tests" taking too long.
A new study identifies changes in metabolism in babies when mothers consumed sweeteners during pregnancy, potentially heightening their risk of obesity.
Scientists say exercising at different times can benefit the body in different ways because of circadian rhythm, and can even help to fix a faulty body clock.
First patient-derived stem cell model for studying eye conditions related to oculocutaneous albinism developed by the National Eye Institute
Lead author of the report, Doctor...
Research shows that T cells, created by the common cold, can give some protection against COVID - which means that universal vaccines can mimic this technology.
According to a new study, nearly one in five patients with heart disease use mental health drugs, leading to almost a doubled risk of premature deaths with the condition.
Scientists analysed 23,754 menstrual cycles to find that menstruation can be temporarily, harmlessly changed - by taking two mRNA vaccines during the same cycle.
Research has found that countries with higher success in minimising coronavirus cases and deaths, have more trust within their society and governments.
A Health Committee report finds that in the "most optimistic scenario" of increased treatment over the next three years, the NHS backlog could come down to pre-pandemic levels in 2025.
In Israel, healthcare professionals and those over 60 are now being encouraged to take the fourth booster dose - which appears to significantly increase waning third dose antibodies.
